Serial 98354497
Live / Allowed — Notice of allowance issued (as of 06 May 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 12 Jan 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98354497
- Mark type
- Design / logo
- Filed
- 12 Jan 2024
- Published for opposition
- 11 Mar 2025
- Attorney of record
- Allison Strickland Ricketts
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for human use for the treatment of adrenal insufficiency; pharmaceutical preparations for human use for the treatment of hormonal and genetic diseases, disorders and conditions; pharmaceutical preparations for the diagnosis, prevention and treatment of endocrine diseases and disorders; pharmaceutical preparations for the treatment of congenital adrenal hyperplasia; pharmaceuticals for human use for the treatment of rare and orphan hormonal and genetic diseases, disorders and conditions
- Class 042 — Scientific and technological services: providing medical research information in the field of pharmaceuticals and clinical trials focusing on congenital adrenal hyperplasia and other endocrine diseases and disorders; Conducting clinical trials for pharmaceutical preparations for the treatment of congenital adrenal hyperplasia and other endocrine diseases and disorders; conducting post-authorization research for the marketing of pharmaceutical preparations and evaluating epidemiological results
- Class 044 — Medical, beauty and agricultural services: Providing medical information to patients, medical professionals, and insurance companies in the field of congenital adrenal hyperplasia and other endocrine diseases and disorders; on-line information services, namely, providing medical information to patients, medical professionals, and insurance companies in the field of congenital adrenal hyperplasia and other endocrine diseases and disorders
Owner
- Neurocrine Biosciences, Inc., San Diego, CA, US
- Neurocrine Biosciences, Inc., San Diego, CA, US
Prosecution history
- 04 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 06 May 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 20 Mar 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 20 Mar 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 20 Mar 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 11 Mar 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 11 Mar 2025 — PUBLISHED FOR OPPOSITION
- 05 Mar 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 14 Feb 2025 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 14 Feb 2025 — ASSIGNED TO LIE
- 12 Feb 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 07 Feb 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 07 Feb 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 07 Feb 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 27 Aug 2024 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED